Patent details

EP2945651 Title: MDR E. COLI SPECIFIC ANTIBODY

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2945651
WO Application Number:
EP2014050895
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP14703783.2
WO Publication Number:
WO2014111516
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Austria (AT)
Publications:

Dates

Filing date:
17/01/2014
Grant date:
07/03/2018
EP Publication Date:
25/11/2015
WO Publication Date:
24/07/2014
Claims Translations Received Date:
Claims Translation B1 Received Date:
01/06/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
07/03/2018
EP B1 Publication Date:
07/03/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
16/01/2034
Lapsed By Expiration Date:
Patent Validated Date:
20/06/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
23/12/2022
 
 

 

Name:
Janssen Pharmaceuticals, Inc.
Address:
1125 Trenton-Harbourton Road, 08560, Titusville, New Jersey, United States of America (US)

Historical Applicant/holder

From:
17/10/2019
To:
23/12/2022

 

Name:
X4 Pharmaceuticals (Austria) GmbH
Address:
Helmut-Qualtinger-Gasse 2, 1030, VIENNA, Austria (AT)

From:
07/03/2018
To:
17/10/2019

 

Name:
ARSANIS Biosciences GmbH
Address:
Helmut-Qualtinger-Gasse 2, 1030 VIENNA, Austria (AT)

Agent

Name:
ir. J.D. de Zeeuw
From:
19/06/2018
Address:
Murgitroyd & Company Scotland House 165 - 169 Scotland Street, G5 8PL, Glasgow, United Kingdom (GB)
To:

Inventor

1

Name:
NAGY, Eszter
Address:
1070 Wien, Austria (AT)

2

Name:
NAGY, Gábor
Address:
9400 Sopron, Hungary (HU)

3

Name:
SZIJÁRTO, Valéria
Address:
1160 Vienna, Austria (AT)

4

Name:
MAGYARICS, Zoltán
Address:
1110 Vienna, Austria (AT)

5

Name:
MIRKINA, Irina
Address:
1020 Vienna, Austria (AT)

6

Name:
GUACHALLA, Luis
Address:
1210 Vienna, Austria (AT)

7

Name:
BADARAU, Adriana
Address:
1030 Vienna, Austria (AT)

8

Name:
ZAUNER, Gerhild
Address:
1040 Vienna, Austria (AT)

9

Name:
LUKASIEWICZ, Jolanta
Address:
53-201 Wroclaw, Poland (PL)

Priority

Priority Patent Number:
13151627
Priority Date:
17/01/2013
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
A61K 39/395; A61P 31/04; C07K 16/12;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
01/23
Publication date:
04/01/2023
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
CO
Journal edition number:
43/19
Publication date:
23/10/2019
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
EP2
Journal edition number:
12/18
Publication date:
14/03/2018
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201810
Publication date:
07/03/2018
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202203151A
Date Registered:
23/12/2022
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. J.D. de Zeeuw
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Janssen Pharmaceuticals, Inc.
Address:
1125 Trenton-Harbourton Road, 08560, Titusville, New Jersey, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC201902070A
Date Registered:
17/10/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. J.D. de Zeeuw
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
X4 Pharmaceuticals (Austria) GmbH
Address:
Helmut-Qualtinger-Gasse 2, 1030, VIENNA, Austria (AT)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/01/2026
Grace Period End Date:
31/07/2026
Annual Fee Number:
13
Annual Fee Amount:
700 Euro
Penalty Fee Amount:
350 Euro
Last Annual Payment Date:
27/01/2025
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
600 Euro
Payer:
Computer Packages Inc. (CPI)
Filing date Document type Document Description Number of pages File Type
19/06/2018 Outgoing Correspondence Letter no formal defects 1 PDF /6/3/2/7/4/0800247236/docs/ep14703783.2_0_213255l271.pdf
01/06/2018 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /6/3/2/7/4/0800247236/docs/ep14703783.2_1_incomingcorrespondenceelectronic20180601160916087.pdf
01/06/2018 Claims First filed claims 3 PDF /6/3/2/7/4/0800247236/docs/ep14703783.2_2_claims20180601160914980.pdf